A patient recounts sudden vision changes leading to brain tumor surgery and a switch from immunotherapy to targeted therapy and new TIL treatment. Patient recounts IL‑2 therapy chills, rigors, ICU ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results